Related Experiment Video

Updated: May 5, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K

Shenqi particle: a novel therapy for idiopathic membranous nephropathy

Madhav C Menon1, Peter Y Chuang, John Cijiang He

  • 1Icahn School of Medicine, Mount Sinai, New York.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|November 26, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

1.6K
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

10.7K

Related Experiment Videos

Last Updated: May 5, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K
Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

1.6K
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

10.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

1.2K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K

Articles linked to this work by shared authors, journal, and citation graph.

Quantifying donor-recipient mismatches using recipient-derived sources of donor DNA.

medRxiv : the preprint server for health sciences·2026

APOL1 risk alleles modulate T cell receptor signaling to promote allograft rejection.

The Journal of clinical investigation·2026

ALDH1A1 is a potential novel target for treatment of ADPKD.

Kidney international·2026

Current Landscape and Emerging Therapeutic Targets in Diabetic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN·2026

Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interaction.

Nature communications·2025

Mechanisms of Podocyte Injury in Kidney Allografts.

Kidney360·2025

Donor Self-Esteem Before and After Living Kidney Donation.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Advances in Understanding of Long-Term Living Kidney Donor Risks.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

12-year Follow-up of a Family With CKD Caused by an mtDNA Variant.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Blood Pressure, Kidney Function, and Kidney Mortality Among Mexican Adults.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Artificial Intelligence-Enabled Electrocardiography for Monitoring Serum Potassium Dynamics in Patients With Severe Hypokalemia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Evidence for the Use of Steroidal Aldosterone Antagonists in Patients With Kidney Failure.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Size-dependent surface engineering of magnetic micro/nanorobots for synergistic chemo-magnetothermal cancer therapy.

Chemical communications (Cambridge, England)·2026

A rare case of giant congenital melanocytic nevus: its embryological and molecular basis.

Folia medica·2026

Symmetry-Tunable Skyrmions and Merons in Magnetic Nanodisks via Spatially Engineered Anisotropy.

Nano letters·2026

Enhancing Lipid Nanoparticle-Mediated Circular RNA and mRNA Expression in the Placenta through Inhibition of IFNAR-JAK-STAT Signaling.

Nano letters·2026

Mirror Life and the Case for Adaptive Risk Governance.

Health security·2026

Nitric oxide-assisted lipid nanoparticles amplify mRNA vaccine responses.

Journal of controlled release : official journal of the Controlled Release Society·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us